Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-18
DOI
10.1038/s41598-020-59736-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
- (2019) Johann S de Bono et al. LANCET ONCOLOGY
- Icon immunoconjugate treatment results in regression of red lesions in a non-human primate ( Papio anubis ) model of endometriosis
- (2018) Demetra Hufnagel et al. Reproductive Biology
- Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON
- (2018) Zhiwei Hu et al. Cancer Immunology Research
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Treating Tissue Factor-Positive Cancers With Antibody-Drug Conjugates That Do Not Affect Blood Clotting
- (2018) Jan-Willem Theunissen et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- The Tissue Factor Pathway and Wound Healing
- (2017) Maureane Hoffman SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy
- (2016) Zhiwei Hu et al. ANGIOGENESIS
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer
- (2016) Zhiwei Hu et al. Oncotarget
- Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG mice
- (2016) Qing Zhang et al. Oncotarget
- Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8
- (2015) Qi Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
- (2015) E. Verronèse et al. OncoImmunology
- Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin
- (2014) Gabriela Cesarman-Maus et al. THROMBOSIS RESEARCH
- Molecularly targeted therapies for metastatic triple-negative breast cancer
- (2013) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer
- (2011) Cornelia Liedtke et al. Breast Care
- Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy
- (2011) J Duanmu et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metastatic Triple-negative Breast Cancer
- (2011) E.A. Rakha et al. CLINICAL ONCOLOGY
- Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
- (2011) J. Cheng et al. CURRENT CANCER DRUG TARGETS
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple-Negative Breast Cancer: An Unmet Medical Need
- (2011) C. A. Hudis et al. ONCOLOGIST
- Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
- (2011) Abderrahim El Guerrab et al. PLoS One
- Regulation of NK92-MI Cell Cytotoxicity by Substance P
- (2011) W. X. Fu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization?
- (2010) N. Berrada et al. ANNALS OF ONCOLOGY
- Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivoin mice
- (2010) Zhiwei Hu et al. BMC CANCER
- Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer
- (2010) Zhiwei Hu et al. BMC IMMUNOLOGY
- Tissue factor in cancer progression and angiogenesis
- (2010) Wolfram Ruf et al. THROMBOSIS RESEARCH
- The Immunoconjugate “Icon” Targets Aberrantly Expressed Endothelial Tissue Factor Causing Regression of Endometriosis
- (2009) Graciela Krikun et al. AMERICAN JOURNAL OF PATHOLOGY
- Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
- (2009) Farrah Kassam et al. Clinical Breast Cancer
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started